期刊文献+

慢性阻塞性肺疾病患者肺组织丙二醛、白细胞介素8、肿瘤坏死因子α水平及吸烟的影响 被引量:12

Levels of Malonaldehyde,Interleukin-8 and Tumor Necrosis Factorα in Lung Tissues from Patients with and without Chronic Obstructive Pulmonary Disease and Effects of Cigarette Smoking
下载PDF
导出
摘要 目的观察慢性阻塞性肺疾病(COPD)患者肺组织的丙二醛(MDA)、白细胞介素8(IL-8)与肿瘤坏死因子α(TNF-α)水平,探讨其在COPD发病中的作用。方法采用酶联免疫吸附试验(ELISA)检测COPD患者中的吸烟者、曾经吸烟者、非吸烟者及非COPD患者中的吸烟者、曾经吸烟者、非吸烟者的肺组织MDA、IL-8与TNF-α含量,采用肺组织匀浆的肌酐浓度进行校正。结果COPD患者肺组织MDA、IL-8和TNF-α水平明显高于非COPD患者(P<0.01)。无论罹患COPD与否,吸烟者肺组织MDA、IL-8和TNF-α水平均明显高于非吸烟者(P<0.05);COPD患者中的吸烟者肺部MDA、TNF-α水平显著高于曾经吸烟者(P<0.05),但二者肺部IL-8水平无明显差异(P>0.05);非COPD患者中的吸烟者肺组织TNF-α水平显著高于曾经吸烟者(P<0.05),但肺组织MDA、IL-8水平差异无统计学意义(P>0.05)。结论长期吸烟可引起肺组织MDA、IL-8和TNF-α水平异常升高,可能在COPD的发病中起重要作用。 Objective To observe the levels of malonaldehyde(MDA),i nter leukin-8(IL-8) and tumor necrosis factor-α(TNF-α) in lung tissues of sub ject s with or without chronic obstructive pulmonary disease(COPD),and investigate their roles in the the pathogenesis of COPD.Methods The cont ent of MDA,IL-8 and TNF-α in lung tissues of smokers with COPD(n=9),ex-smokers with COP D(n=8),non-smokers with COPD(n=7),healthy smokers(n=9),healthy ex-smok ers(n=8) and healthy non-smokers(n=6) was measured with enzyme-linked immunosorben t ass ay(ELISA) and corrected by creatinine.Results The levels of MDA,IL-8 and TNFα in lung tissues of the COPD patients were significantly higher than those in the heal thy subjects(P0.05),which were also significantly higher in the smokers when comp ared with the non-smokers(P0.05),whether suffering from COPD or not.In the COPD pa tients, not the levels of IL-8 but MDA and TNF-α in lung tissues of the smokers were sig ni ficantly higher than those in the ex-smokers(P0.05);whereas in the healthy case s,no statistical significance was revealed between the smokers and the ex-smokers on the leve l s of MDA and IL-8 in lung tissues except TNF-α(P0.05).Conclu sion The abnorm al increase of MDA,IL-8 and TNF-α in lung tissues caused by chronic smoking may play an important role in the the pathogenesis of COPD.
出处 《中国呼吸与危重监护杂志》 CAS 2012年第3期218-222,共5页 Chinese Journal of Respiratory and Critical Care Medicine
基金 四川省中医药管理局科研基金(编号:05SZYJ-116) 四川大学华西医院SCI基金(编号:141070062)
关键词 慢性阻塞性肺疾病 吸烟 丙二醛 白细胞介素8 肿瘤坏死因子Α Chronic obstructive pulmonary disease Smoking Malonaldehyde Interleukin-8 Tumor necrosis factor-α
  • 相关文献

参考文献17

  • 1GOLD Executive Committee [ DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2007). http://www. Goldcopd. org.
  • 2Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J, 2006,27:397-412.
  • 3Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD) : Rationale and Design. J COPD, 2005,2:277-283.
  • 4MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005,2 : 50-60.
  • 5Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest, 1997, 112: 505-510.
  • 6Sato T, Sayama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Criti Care Med, 2006,174:530-537.
  • 7何娓娓,顾宇彤,王桂芳.氧化应激失衡在慢性阻塞性肺疾病患者发病及防治中的研究进展[J].中国呼吸与危重监护杂志,2011,10(2):200-201. 被引量:14
  • 8Macnee W. Oxidants/ antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy. Novartis Found Symp, 2001,234 : 169-188.
  • 9Macnee W, Donaldson K. Exacerbations of COPD: environmental mechanisms. Chest, 2000,117 (5 S2) :390S-397S.
  • 10Barnes PJ. Mediators of chronic obsructive pulmonary disease. Pharmacol Rev, 2004,56 : 515-548.

二级参考文献3

  • 1Pietro B,Bracciale,Salvatore Bellanova,Antonio Castagnaro,et al.Alveolar macrophage activity and its correlation with burden ofreactive oxygen species in bronchoalveolar fluid and in the serum ofpatients affected by chronic obstructive pulmonary disease III-IVGOLD Stage. ACCP 2009 .
  • 2Michael Ellison,Gail Thurman,Daniel R Ambruso.Neutrophil p29Peroxiredoxin VI/aiPLA2(p29 Prdx VI)Enhances SuperoxideProduction by the NADPH Oxidase in a Manner Dependent On thePLA2 Active Site. Blood . 2009
  • 3Zheng JP,Yang L,Wu YM,et al.The efficacy and safety of combination salmeterol(50microg)/fluticasone propionate(500microg)inhalation twice daily via accuhaler in Chinese patients with COPD. Chest . 2007

共引文献13

同被引文献122

引证文献12

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部